These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26088116)

  • 1. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.
    Hulse G; Kelty E; Hood S; Norman A; Basso MR; Reece AS
    Curr Pharm Des; 2015; 21(23):3325-42. PubMed ID: 26088116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.
    Sabioni P; Bertram J; Le Foll B
    Curr Pharm Des; 2015; 21(23):3306-10. PubMed ID: 26088120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of flumazenil in the critically ill.
    Park GR; Navapurkar V; Ferenci P
    Acta Anaesthesiol Scand Suppl; 1995; 108():23-34. PubMed ID: 8693921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy and role of antibenzodiazepines.
    Hammond JB; Ahmad F
    Am J Ther; 1998 Jan; 5(1):33-6. PubMed ID: 10099035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil, a GABA antagonist, may improve features of Parkinson's disease.
    Ondo WG; Hunter C
    Mov Disord; 2003 Jun; 18(6):683-5. PubMed ID: 12784272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of coumarins towards central nervous system disorders.
    Skalicka-Woźniak K; Orhan IE; Cordell GA; Nabavi SM; Budzyńska B
    Pharmacol Res; 2016 Jan; 103():188-203. PubMed ID: 26657416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flumazenil for the reversal of refractory benzodiazepine-induced shock.
    Coates W; Evans TC; Jehle D; Harchelroad F; Isaacs M
    J Toxicol Clin Toxicol; 1991; 29(4):537-42. PubMed ID: 1749058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAB Agonists for the Treatment of Alcohol Use Disorder.
    Mirijello A; Caputo F; Vassallo G; Rolland B; Tarli C; Gasbarrini A; Addolorato G
    Curr Pharm Des; 2015; 21(23):3367-72. PubMed ID: 26088121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology.
    Lang S
    Curr Med Chem; 2002 Aug; 9(15):1411-5. PubMed ID: 12173979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate- and GABA-based CNS therapeutics.
    Foster AC; Kemp JA
    Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind trial of flumazenil in hemiballismus.
    Kulisevsky J; Avila A; Berthier ML; Barbanoj M
    Clin Neuropharmacol; 1994 Oct; 17(5):470-2. PubMed ID: 9316697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.
    Weinbroum AA; Flaishon R; Sorkine P; Szold O; Rudick V
    Drug Saf; 1997 Sep; 17(3):181-96. PubMed ID: 9306053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABA-benzodiazepine receptor ionophore complex in cerebral cortex of rat.
    Kulkarni SK; Ticku MK
    Brain Res; 1990 Jun; 519(1-2):6-11. PubMed ID: 2168788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil reversal of carisoprodol (Soma) intoxication.
    Roberge RJ; Lin E; Krenzelok EP
    J Emerg Med; 2000 Jan; 18(1):61-4. PubMed ID: 10645840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central benzodiazepine receptors in the spinal cord and other regions of the CNS of the cat.
    Luzzani F; Colombo G; Glässer A
    Neuropharmacology; 1984 Oct; 23(10):1137-40. PubMed ID: 6151628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flumazenil selectively prevents the increase in alpha(4)-subunit gene expression and an associated change in GABA(A) receptor function induced by ethanol withdrawal.
    Biggio F; Gorini G; Caria S; Murru L; Sanna E; Follesa P
    J Neurochem; 2007 Aug; 102(3):657-66. PubMed ID: 17403139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report.
    Kelty E; Martyn V; O'Neil G; Hulse G
    J Psychopharmacol; 2014 Jul; 28(7):703-6. PubMed ID: 24554692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System.
    Gazulla J; Ruiz-Gazulla C; Tintore M
    Curr Pharm Des; 2015; 21(34):4989-95. PubMed ID: 26365142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients.
    Trotti LM; Saini P; Koola C; LaBarbera V; Bliwise DL; Rye DB
    J Clin Sleep Med; 2016 Oct; 12(10):1389-1394. PubMed ID: 27568889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial.
    Ondo WG; Silay YS
    Mov Disord; 2006 Oct; 21(10):1614-7. PubMed ID: 16830315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.